Category Archives: Global News Feed

Utilizing decades of experience, Paschal will bring his strategic leadership and technical know-how to Growcentia as the company continues to expand Utilizing decades of experience, Paschal will bring his strategic leadership and technical know-how to Growcentia as the company continues to expand

Read more:
Update: Growcentia appoints Darrin Paschal as new chief commercial officer

October 27, 2022

Originally posted here:
argenx Reports Third Quarter 2022 Financial Results and Provides Business Update

PRESS RELEASE

See the original post here:
Indigo Diabetes Incorporates Fully Owned Subsidiary in the US and Appoints Peter J. Devlin as President, Indigo Medical US Inc.

Ad hoc announcement pursuant to Art. 53 LR

Originally posted here:
Santhera and ReveraGen Complete NDA Submission to FDA for Vamorolone in Duchenne Muscular Dystrophy

Basel, 27 October 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive topline results from two global phase III studies, BALATON and COMINO, evaluating the first and only bispecific antibody for the eye, Vabysmo® (faricimab), in macular edema due to branch and central retinal vein occlusion (BRVO and CRVO).1,2,3 RVO is a vision-threatening condition that impacts 28 million people globally.4

Read the original post:
Positive topline phase III results show Roche's Vabysmo improved vision for people living with retinal vein occlusion (RVO)

PRESS RELEASE                      27 OCTOBER 2022 AT 8.00 a.m. EEST

Visit link:
Orion Research Foundation is awarding EUR 1 million in grants and two EUR 100,000 special grants today